V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280011050 | 280008667 | 1.64 | null | Palliative (P) | 2017-11-20 | 2018-02-03 | Docetaxel + Gemcitabine (prior RT) | 01 | N | 280025459 | DOCETAXEL + GEMCITABINE |
| 280011051 | 280010398 | null | null | Palliative (P) | null | 2015-09-01 | Docetaxel + Gemcitabine (prior RT) | N | Y | 280025465 | DOCETAXEL + GEMCITABINE |
| 280011052 | 280010401 | 1.7 | null | Neo-adjuvant (N) | 2018-08-18 | 2018-08-30 | Docetaxel + Gemcitabine with GCSF | 02 | N | 280025489 | DOCETAXEL + GEMCITABINE |
| 280011053 | 280005052 | null | 57.3 | Neo-adjuvant (N) | 2014-03-25 | 2015-04-21 | Docetaxel + Gemcitabine (prior RT) | N | Y | 280025505 | DOCETAXEL + GEMCITABINE |
| 280011054 | 280005056 | null | 83.2 | Palliative (P) | 2016-09-10 | 2016-09-10 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 2 | N | 280025512 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280011055 | 280005058 | 1.54 | 10.8 | Not known (9) | 2016-12-11 | 2016-12-11 | Carboplatin AUC 6 - 10 | N | N | 280025518 | CARBOPLATIN |
| 280011056 | 280005060 | 1.82 | null | Palliative (P) | 2017-06-05 | 2017-07-20 | Carboplatin AUC 2 - 5 | N | null | 280025519 | CARBOPLATIN |
| 280011057 | 280005063 | 1.52 | 78.5 | Palliative (P) | null | 2016-08-06 | EW Rel rEECur Topotecan/Cyclophosphamide | null | null | 280025522 | NOT MATCHED |
| 280011058 | 280008681 | 1.8 | 76.9 | Palliative (P) | 2015-02-24 | 2015-02-24 | Docetaxel + Gemcitabine with GCSF | N | Y | 280025524 | DOCETAXEL + GEMCITABINE |
| 280011059 | 280005066 | null | 79.7 | Palliative (P) | null | 2014-02-07 | Cetuximab 7 day (>Cycle 2) | Y | N | 280025525 | CETUXIMAB |
| 280011060 | 280008684 | 1.69 | 130.6 | Palliative (P) | 2015-09-21 | 2015-10-15 | CETUXIMAB | N | N | 280025532 | CETUXIMAB |
| 280011061 | 280005073 | 1.8 | 91 | Neo-adjuvant (N) | 2016-08-10 | 2016-09-28 | Docetaxel + Gemcitabine (prior RT) | N | null | 280025541 | DOCETAXEL + GEMCITABINE |
| 280011062 | 280005076 | 1.7 | null | Palliative (P) | 2018-07-20 | 2018-07-20 | Carboplatin AUC 6 - 10 | 02 | null | 280025545 | CARBOPLATIN |
| 280011063 | 280005081 | null | null | Curative (C) | 2018-12-12 | 2018-12-26 | CETUXIMAB | N | N | 280025551 | CETUXIMAB |
| 280011064 | 280005083 | null | 14.2 | Palliative (P) | 2018-12-11 | 2018-12-14 | Docetaxel + Gemcitabine with GCSF | null | null | 280025552 | DOCETAXEL + GEMCITABINE |
| 280011065 | 280005086 | null | 70.2 | Palliative (P) | 2014-10-09 | 2014-11-25 | Cisplatin + Docetaxel +Fluorouracil | N | N | 280025560 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280011066 | 280008696 | 1.5 | 65.16 | Disease modification (D) | 2015-02-07 | 2015-10-04 | Docetaxel + Gemcitabine (prior RT) | null | null | 280025571 | DOCETAXEL + GEMCITABINE |
| 280011067 | 280008696 | 1.74 | null | Curative (C) | 2017-02-08 | 2017-04-09 | Carboplatin AUC 2 - 5 | 02 | N | 280025571 | CARBOPLATIN |
| 280011068 | 280005095 | 0.85 | 73 | Palliative (P) | 2013-01-02 | 2014-07-29 | Olaratumab | 2 | N | 280025581 | NOT MATCHED |
| 280011070 | 280005100 | null | 67 | Palliative (P) | 2016-09-05 | 2016-12-04 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 280025588 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280011071 | 280005108 | 1.08 | null | Curative (C) | 2014-03-01 | 2014-08-24 | EW EuroEwing 2012 Arm A VAC | 02 | N | 280025596 | NOT MATCHED |
| 280011072 | 280005111 | null | 22 | Curative (C) | 2017-06-28 | 2017-08-30 | NB Rel CCLG guidelines Irin & Temoz | 02 | null | 280025603 | NOT MATCHED |
| 280011073 | 280005122 | 1.73 | 94.8 | Palliative (P) | 2016-12-30 | 2017-01-13 | Docetaxel + Gemcitabine with GCSF | 02 | null | 280025635 | DOCETAXEL + GEMCITABINE |
| 280011074 | 280005127 | 1.8 | 65.75 | Palliative (P) | 2016-09-08 | 2016-10-03 | Carboplatin AUC 6 - 10 | 02 | N | 280025639 | CARBOPLATIN |
| 280011075 | 280005129 | 1.65 | 53.1 | Neo-adjuvant (N) | 2014-08-28 | 2014-08-28 | Docetaxel+Gemcitabine (no prior RT) | N | N | 280025646 | DOCETAXEL + GEMCITABINE |
| 280011076 | 280010427 | 1.8 | 90.9 | Curative (C) | 2012-10-27 | 2013-04-07 | NB HRNBL-1 ch14.18/CHO only (trial) | 02 | null | 280025646 | NOT MATCHED |
| 280011077 | 280005132 | 1.8 | 101 | Palliative (P) | 2015-03-23 | 2015-03-30 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | Y | 280025652 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280011078 | 280005149 | null | null | Palliative (P) | 2018-02-05 | 2018-02-22 | Cisplatin + Docetaxel +Fluorouracil | N | null | 280025728 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280011079 | 280005152 | 1.82 | 84.8 | null | 2015-01-28 | 2015-02-04 | Carboplatin AUC 6 - 10 | N | N | 280025730 | CARBOPLATIN |
| 280011080 | 280011273 | null | 73.3 | Palliative (P) | 2016-08-07 | 2016-08-31 | Cetuximab 7 day (>Cycle 2) | 02 | null | 280025738 | CETUXIMAB |
| 280011081 | 280005155 | 1.63 | 78.5 | Palliative (P) | 2014-01-29 | 2014-02-17 | Cetuximab 7 day (>Cycle 2) | N | N | 280025740 | CETUXIMAB |
| 280011082 | 280005161 | 1.57 | 56.8 | Neo-adjuvant (N) | 2017-07-23 | 2017-08-02 | Docetaxel + Gemcitabine (prior RT) | 02 | N | 280025749 | DOCETAXEL + GEMCITABINE |
| 280011083 | 280005170 | 1.76 | 65 | Palliative (P) | 2018-03-02 | 2018-03-21 | Docetaxel + Gemcitabine (prior RT) | N | N | 280025770 | DOCETAXEL + GEMCITABINE |
| 280011084 | 280005178 | null | null | Palliative (P) | 2017-03-04 | 2017-03-31 | Cisplatin + Docetaxel +Fluorouracil | 01 | null | 280025794 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 280011085 | 280005185 | 1.77 | 74.4 | Palliative (P) | 2018-01-08 | 2018-05-04 | Docetaxel + Gemcitabine with GCSF | 2 | N | 280025810 | DOCETAXEL + GEMCITABINE |
| 280011086 | 280005189 | null | 71 | Palliative (P) | 2016-06-07 | 2016-12-20 | STS Rhabdo VIT0910 Vinc Irino Temoz | 02 | N | 280025820 | NOT MATCHED |
| 280011087 | 280005191 | 1.54 | 68.9 | Neo-adjuvant (N) | 2013-06-15 | 2013-06-19 | EW EuroEwing 2012 Arm B VC | Y | N | 280025821 | NOT MATCHED |
| 280011088 | 280005194 | 1.65 | null | Adjuvant (A) | 2014-08-20 | 2015-09-27 | Docetaxel + Gemcitabine with GCSF | N | N | 280025828 | DOCETAXEL + GEMCITABINE |
| 280011089 | 280005195 | 1.68 | 31 | Palliative (P) | null | 2015-09-04 | Cetuximab 7 day (>Cycle 2) | N | N | 280025832 | CETUXIMAB |
| 280011090 | 280005196 | 1.52 | 125 | Palliative (P) | 2016-09-04 | 2016-09-19 | null | Y | N | 280025836 | NOT MATCHED |
| 280011091 | 280005198 | 1.92 | null | Palliative (P) | 2015-03-09 | 2015-03-20 | Docetaxel + Gemcitabine (prior RT) | Y | N | 280025839 | DOCETAXEL + GEMCITABINE |
| 280011092 | 280005201 | 1.74 | null | Not known (9) | 2017-12-30 | 2017-12-30 | Paclitaxel 7 day | N | N | 280025853 | PACLITAXEL |
| 280011093 | 280008753 | 1.65 | 70 | Palliative (P) | 2015-11-11 | 2015-11-19 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 280025861 | PACLITAXEL |
| 280011094 | 280010449 | 1.78 | 21.9 | Palliative (P) | 2014-01-26 | 2014-01-29 | Cisplatin | 2 | N | 280025889 | CISPLATIN |
| 280011095 | 280005214 | 1.67 | null | Neo-adjuvant (N) | 2014-05-30 | 2014-06-23 | Ifosfamide | N | N | 280025900 | IFOSFAMIDE |
| 280011096 | 280005223 | 1.67 | 75 | Adjuvant (A) | 2017-11-19 | 2018-01-16 | CARBOPLATIN + RT | 2 | Y | 280025920 | CARBOPLATIN + RT |
| 280011097 | 280010451 | 1.54 | 75.7 | Palliative (P) | 2013-05-26 | 2013-05-27 | Cetuximab + Radiotherapy Maint | null | null | 280025923 | CETUXIMAB + RT |
| 280011098 | 280005231 | 1.56 | 98 | Neo-adjuvant (N) | 2018-02-21 | 2018-02-21 | Ifosfamide | Y | N | 280025954 | IFOSFAMIDE |
| 280011099 | 280005233 | 1.69 | 92 | Neo-adjuvant (N) | 2015-01-22 | 2015-12-31 | Doxorubicin 75mg/m2 | N | N | 280025956 | DOXORUBICIN |
| 280011100 | 280005241 | null | 93.8 | Curative (C) | null | 2016-06-20 | CARBOPLATIN + RT | null | null | 280025984 | CARBOPLATIN + RT |